The EU has been a leader in research and development of in vitro biotechnology (IVB), such as human 3D cell and tissue models used in disease research and drug development. However, it is struggling to convert scientific discoveries into business creation and competitiveness within a rapidly growing international market.
MENNECOZZI Milena;
PIERGIOVANNI Monica;
SELFA ASPIROZ Lucia;
WHELAN Maurice;
2026-02-11
ELSEVIER SCIENCE LONDON
JRC141680
1879-3096 (online),
https://www.sciencedirect.com/science/article/pii/S016777992500280X,
https://publications.jrc.ec.europa.eu/repository/handle/JRC141680,
10.1016/j.tibtech.2025.07.019 (online),
| Name | Country | City | Type |
|---|
This document is only visible at the Commission level.
You are not authorized to publish or distribute it outside the European Commission.
This is a public document. You can share this publication.
Datasets
| ID | Title | Public URL |
|---|
Dataset collections
| ID | Acronym | Title | Public URL |
|---|
Scripts / source codes
| Description | Public URL |
|---|
Additional supporting files
| File name | Description | File type |
|---|